Managing genetic tests, surveillance, and preventive medicine under a public health insurance system

Brown, 2002, Estimating health care costs related to cancer treatment from SEER-medicare data, Medical Care, 40, 104 Bardey, 2013, Genetic Testing with Primary Prevention and Moral Hazard, Journal of Health Economics, 32, 768, 10.1016/j.jhealeco.2013.04.008 Caulfield, 2008, Nutrigenomics and the promise of prevention: representations and realities, Health Law Journal, 41 Cohen, 2008, Does preventive care save money? Health economics and the presidential candidates, New England Journal of Medicine, 358, 661, 10.1056/NEJMp0708558 Crainich, 2011 Crocker, 1985, A simple tax structure for competitive equilibrium and redistribution in insurance markets with asymmetric information, Southern Economic Journal, 51, 1142, 10.2307/1058384 Crocker, 1986, The efficiency effects of categorical discrimination in the insurance industry, Journal of Political Economy, 94, 321, 10.1086/261376 Davies, 2010 Doherty, 1998, On the value of a checkup: adverse selection, moral hazard and the value of information, Journal of Risk and Insurance, 65, 189, 10.2307/253533 Filipova-Neumann, 2009 Finkelstein, 2008 Harrington, 2010, U.S. health-care reform: the patient protection and affordable care act, Journal of Risk and Insurance, 77, 703, 10.1111/j.1539-6975.2010.01371.x Hirshleifer, 1992 Hoel, 2002, Genetic testing when there is a mix of compulsory and voluntary health insurance, Journal of Health Economics, 21, 253, 10.1016/S0167-6296(01)00112-6 Hoy, 1982, Categorizing risk in the insurance industry, Quarterly Journal of Economics, 97, 321, 10.2307/1880761 Hoy, 1984, The impact of imperfectly categorizing risk on income inequality and social welfare, Canadian Journal of Economics, 17, 557, 10.2307/135192 Hoy, 1989, The value of screening mechanisms under alternative insurance possibilities, Journal of Public Economics, 39, 177, 10.1016/0047-2727(89)90039-X Hoy, 2000, The value of genetic information in the life insurance market, Journal of Public Economics, 78, 235, 10.1016/S0047-2727(99)00118-8 Hoy, 2005, Regulating genetic information in insurance markets, Risk Management and Insurance Review, 8, 211, 10.1111/j.1540-6296.2005.00057.x Hoy, 2006, Risk classification and social welfare, The Geneva Papers on Risk and Insurance: Issues and Practice, 31, 245, 10.1057/palgrave.gpp.2510079 Hoy, 2007, Welfare effects of banning genetic information in the life insurance market: the case of BRCA1/2 genes, Journal of Risk and Insurance, 74, 523, 10.1111/j.1539-6975.2007.00223.x Hoy, 2014, Take-up for genetic tests and ambiguity, Journal of Risk and Uncertainty, 10.1007/s11166-014-9186-z Kifmann, 2001, Premium risk and managed care, Journal of Risk and Uncertainty, 22, 277, 10.1023/A:1011187102745 Lansdorp-Vogelaar, 2009, Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening, Journal of the National Cancer Institute, 101, 1412, 10.1093/jnci/djp319 McFadden, 2012 Miller, 2002 O’Doherty, 2007, Risky communication: pitfalls in counseling about risk, and how to avoid them, Journal of Genetic Counseling, 16, 409, 10.1007/s10897-006-9077-9 Rees, 2006, Genetic testing, income distribution, and insurance markets, Annales d’economie et de statistique, 353, 10.2307/20079174 Rothschild, 1976, Equilibrium in competitive insurance markets: an essay on the economics of imperfect information, Quarterly Journal of Economics, 90, 630, 10.2307/1885326 Roukos, 2008, Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery, Expert Review of Molecular Diagnostics, 8, 587, 10.1586/14737159.8.5.587 Sloan, 1998, Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis, Journal of Health Economics, 17, 475, 10.1016/S0167-6296(97)00025-8 Strohmenger, 2000, Adverse selection and categorical discrimination in the health insurance markets: the effects of genetic tests, Journal of Health Economics, 19, 197, 10.1016/S0167-6296(99)00021-1 Tabarrok, 1994, Genetic testing: an economic and contractarian analysis, Journal of Health Economics, 13, 75, 10.1016/0167-6296(94)90005-1 Tengstam, 2007 Wilson, 1977, A model of insurance with incomplete information, Journal of Economic Theory, 16, 167, 10.1016/0022-0531(77)90004-7 Viscusi, 1990, Utility functions that depend on health status: estimates and economic implications, American Economic Review, 80, 353